Compare LULU & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LULU | WST |
|---|---|---|
| Founded | 1998 | 1923 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9B | 16.6B |
| IPO Year | 2007 | 2004 |
| Metric | LULU | WST |
|---|---|---|
| Price | $173.43 | $250.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 25 | 7 |
| Target Price | $212.97 | ★ $319.43 |
| AVG Volume (30 Days) | ★ 1.9M | 915.2K |
| Earning Date | 03-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | ★ 20.00 | 1.49 |
| EPS | ★ 8.29 | 6.79 |
| Revenue | ★ $10,588,126,000.00 | $2,886,900,000.00 |
| Revenue This Year | $6.59 | $6.73 |
| Revenue Next Year | $4.40 | $6.07 |
| P/E Ratio | ★ $21.05 | $36.96 |
| Revenue Growth | ★ 10.07 | 1.95 |
| 52 Week Low | $159.25 | $187.43 |
| 52 Week High | $363.88 | $322.34 |
| Indicator | LULU | WST |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 51.94 |
| Support Level | $160.62 | $244.30 |
| Resistance Level | $184.31 | $261.98 |
| Average True Range (ATR) | 6.32 | 8.22 |
| MACD | 0.21 | 1.68 |
| Stochastic Oscillator | 21.33 | 71.47 |
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 780 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.